PRE 14A

PRE 14A Filing

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: March 31, 2017
Period of Report: March 31, 2017
Accession Number: 0001493152-17-003222

View Document ↗ View on SEC.gov ↗